Bringing the fundamentals into focus…
Back to Kyverna Therapeutics, Inc.
How Kyverna Therapeutics, Inc. stacks up
KYTX · against 371 other Healthcare companies of similar size
Profitability
12/ 100
Near the bottom of its peers.
Ranked #309 of 372 · scores higher than 16% of peers
Bars: peers in each 10-point band of the profitability score43 peers with a profitability score of 10–19, including KYTX · Click a bar to see the companies
Why profitability scores 12?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 96% of peers. Return on assets: -69.4% vs peer median 1.7%
- a lower return on invested capital: weaker than 92% of peers. Return on invested capital: -79.2% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = KYTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KYTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 337 reported | -79.2% | 0.5% | 11% | 33% | |
| Operating marginHigher is better · 346 reported | Not reported | 3.0% | — | — | 33% |
| Return on assetsHigher is better · 371 reported | -69.4% | -0.2% | 5% | 33% | |
| Return on equityHigher is better · 351 reported | -87.2% | -0.7% | 9% | Context only | |
| Gross marginHigher is better · 388 reported | 0.0% | 37.8% | 4% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around KYTX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 306 | 534M USD | 13 | 32 | |
| 306 | 5.1B MXN (≈$274M) | 13 | 48 | |
| 309 | 337M USD | 12 | 33 | |
| 309 | 487M USD | 12 | 24 | |
| 309 | 319M USD | 12 | 28 | |
| 309 | 421M USD | 12 | 52 | |
| 309 | 388M USD | 12 | 36 | |
| 309 | 227M USD | 12 | 24 | |
| 315 | 1.8B HKD (≈$236M) | 11 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score